Home
Conditions
Epstein-Barr Virus Infections

Clinical trial condition

Epstein-Barr Virus Infections

Explore clinical trials studying Epstein-Barr Virus Infections. Study availability and eligibility vary by location and protocol.

125 public trials 36 recruiting studies

Refine in advanced search Browse all conditions

Epstein-Barr Virus Infections trial results

Not Yet Recruiting

BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL

NCT07678229

Conditions: DNA Virus Infections, Epstein-Barr Virus Infections, Extranodal NK/T-cell Lymphoma, +10 more
Locations: Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Rituximab for PTLD Prevention in Solid Organ Transplant Recipients With EBV DNAemia

NCT07614282

Conditions: DNA Virus Infections, Epstein Barr Virus (EBV) Infection, Epstein-Barr Virus Infections, +6 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

mRNA Vaccine Targeting Epstein-Barr Virus (EBV) in Healthy Young Adults

NCT07557602

Conditions: DNA Virus Infections, EBV, Epstein-Barr Virus Infections, +4 more
Locations: Q-Pharm Pty Ltd/Nucleus Network Pty Ltd Herston, Queensland, Australia

Nucleus Network Pty Ltd Melbourne, Victoria, Australia

View Trial Details

Not Yet Recruiting

Safety and Tolerability of IDO-1 Inhibition in the Prevention of EBV-related Pathology in EBV Negative Kidney Transplant Recipients Receiving an Organ From EBV Positive Donors

NCT07368153

Conditions: DNA Virus Infections, EBV Infections, Epstein-Barr Virus Infections, +5 more
Locations: University Hospital Basel Basel, Switzerland

View Trial Details

Not Yet Recruiting

Zuberitamab for EBV Infection Post-Allo-HSCT

NCT07261215

Conditions: DNA Virus Infections, EBV Infection, Epstein-Barr Virus Infections, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

EBV Lytic Reactivation Therapy Combined With PD-1 Antibody in Recurrent/Metastatic Nasopharyngeal Carcinoma

NCT07138989

Conditions: Carcinoma, DNA Virus Infections, Epstein-Barr Virus Infections, +18 more
Locations: Sun Yat-sen Universitty Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

Application of PD-1 Inhibitors Combined With Tenofovir, Chidamide and Lenalidomide in the Treatment of EBV-associated Diseases.

NCT07133776

Conditions: Chidamide, DNA Virus Infections, Epstein-Barr Virus (EBV) Infection, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

EBV-Tscm Cytotoxic T Cells (CTLs) for EBV- Driven Lymphomas/ Diseases

NCT05688241

Conditions: DNA Virus Infections, EBV Lymphoma, Epstein-Barr Virus Infections, +5 more
Locations: University Hospital Basel, Klinik für Infektiologie und Spitalhygiene Basel, Switzerland

Universitäts-Kinderspital beider Basel (UKBB) Basel, Switzerland

Universitätsspital Bern, Klinik für Infektiologie Bern, Switzerland

Hôpitaux Universitaires de Genève, Hôpital des Enfants Geneva, Switzerland

View Trial Details

Not Yet Recruiting

Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam Therapy

NCT06480903

Conditions: Carcinoma, DNA Virus Infections, Epstein-Barr Virus, +20 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Graves' Disease Induced by Epstein-Barr Virus Lytic Reactivation

NCT06426758

Conditions: Autoimmune Diseases, DNA Virus Infections, Endocrine System Diseases, +15 more
Locations: Nanjing First Hospital, Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Epstein-Barr Virus Infections

Epstein-Barr Virus Infections trial results

Related conditions